Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Clinical application of extracorporeal membrane oxygenation in children with refractory cardiopulmonary failure
Zi-Hao Yang1, Bo-Tao Ning2, Chen-Mei Zhang1
1Department of PICU, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Insights
Extracorporeal membrane oxygenation (ECMO) effectively supports children with severe cardiopulmonary failure. This therapy, particularly for acute fulminant myocarditis, shows a 58.3% survival rate in pediatric patients.
Area of Science:
- Pediatric Critical Care Medicine
- Cardiovascular Surgery
- Respiratory Support
Background:
- Refractory cardiopulmonary failure presents a critical challenge in pediatric intensive care.
- Extracorporeal membrane oxygenation (ECMO) offers a life-saving intervention for severe cases.
Purpose of the Study:
- To describe the clinical experience of utilizing ECMO in pediatric patients with refractory cardiopulmonary failure.
- To evaluate the efficacy and outcomes of ECMO support in this vulnerable population.
Main Methods:
- Retrospective review of 12 pediatric patients treated with ECMO.
- Data collected from February 2009 to August 2015 in a Pediatric Intensive Care Unit (PICU).
Main Results:
- A survival rate of 58.3% (7/12) was achieved, with successful weaning from ECMO.
- Five patients presented with acute fulminant myocarditis (AFM), a key indication.
- Complications included hemorrhage, hemolysis, thrombosis, acute kidney injury, and infection.
Conclusions:
- ECMO is a valuable therapeutic option for children with refractory cardiopulmonary failure.
- ECMO demonstrates particular utility in the management of acute fulminant myocarditis in pediatric patients.
Background:
This study aimed to discribe the experience in supporting children with refractory cardiopulmonary failure with extracorporeal membrane oxygenation (ECMO).
Methods:
We retrospectively reviewed 12 children with refractory cardiopulmonary failure supported with ECMO from February 2009 to August 2015 in the Pediatric Intensive Care Unit (PICU), Children's Hospital, Zhejiang University School of Medicine.
Results:
Seven of the 12 patients were weaned successfully from ECMO and dischaged from the hospital, with a survival rate of 58.3% (7/12). Among them, five patients had acute fulminant myocarditis (AFM). Complications during ECMO included hemorrhage, hemolysis, thrombosis, acute kidney injury, and secondary hematogenous infection. During 1-24 month follow-up, the seven surviving patients recovered with normal cardiopulmonary function.
Conclusions:
ECMO is useful for supporting children with refractory cardiopulmonary failure, especially for treatment of AFM.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Respiratory Failure-III

